Fosfomycin Tromethamine recalls
The FDA has published 3 recalls involving Fosfomycin Tromethamine since 2023. The latest was reported on 14 Oct 2026. Most were for potency & assay. Ascend Laboratories has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls3since 2023
Last 12 months1reported
Class I00% of total
Ongoing2latest 14 Oct 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 67%Class III 1 33%
Why fosfomycin tromethamine is recalled
Companies
By year
Ongoing fosfomycin tromethamine recalls
2 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Fosfomycin Tromethamine Granules for Oral Solution recalled by Cipla USAFosfomycin Tromethamine | Cipla USA | Potency & Assay | Nationwide |
| Drug | CLASS II | Fosfomycin Tromethamine Granules for Oral Solution recalledFosfomycin Tromethamine | Ascend Laboratories | Potency & Assay | Nationwide |
All fosfomycin tromethamine recalls, newest first
3 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Fosfomycin Tromethamine Granules for Oral Solution recalled by Cipla USAFosfomycin Tromethamine | Cipla USA | Potency & Assay | Nationwide |
| Drug | CLASS II | Fosfomycin Tromethamine Granules for Oral Solution recalledFosfomycin Tromethamine | Ascend Laboratories | Potency & Assay | Nationwide |
| Drug | CLASS III | Fosfomycin Tromethamine Granules recalled by Ascend LaboratoriesFosfomycin Tromethamine | Ascend Laboratories | Potency & Assay | Nationwide |
Should you stop taking Fosfomycin Tromethamine?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.